As they continue to grow, Stigma Grow is
already producing large quantities of both live resin and cured
concentrates for in-house and third-party cannabis
brands.
RED DEER, AB, May 19, 2020
/CNW/ - CanadaBis Capital Inc. ("CanadaBis" or "the Company"), a
vertically integrated Canadian cannabis company focused on finding
and capitalizing on growth and diversification
opportunities, is pleased to announce that its subsidiary
1998643 Alberta Ltd. ("Stigma Grow"), has become the first Canadian
LP to produce and distribute live resin caviar, live resin badder
and cured badder to retailers across Canada.
The Company, who anticipated a shift in consumer behaviour from
a focus on dry flower to a focus on concentrates in 2020 and
beyond, has spent the last few months securing the right-fit
partnerships, processes and personnel, before securing multiple POs
across Canada for their Natural
Gas Liquids (NGL) high-potency concentrates.
On April 19th, the
Company oversaw the shipment of their first 6,000+ packages of
Chapter 1: Cured Badder and has shipped out an additional 28,000
jars of live resin badder and live resin caviar as part of a
toll-processing partnership with the brand Premium 1.
"The future of cannabis is strong, and it's here!", exclaims
Travis McIntyre, President and CEO
of Stigma Grow. "We've spent the last six months perfecting our
systems and constructing a CIDI Lab to house hydrocarbon extraction
processing — positioning us to bring difficult-to-produce products
to market on a mass under our brand, and as a third-party processor
for other high-quality cannabis growers."
Stigma Grow intends to leverage their top-quality flower,
state-of-the-art technology, and the insight provided by their
skilled and experienced staff, to maintain their position as
recognized Canadian leaders in high-quality, 'bud-run' extract
product variations.
Travis explains, "Our vision as a company has always been to
provide our community with what is in-demand, and all signs point
to the need for consistent, high-potency concentrates. The response
and momentum we've seen over the past few months has positioned our
company for the type of growth and influence we've always
envisioned."
As of the date of this release, Stigma Grow is actively pursuing
third-party processing partnerships with local and national LPs and
is quickly becoming recognized as a powerful player in Canada's evolving cannabis industry
landscape.
About CanadaBis Capital Inc.
CanadaBis Capital Inc. (TSXV:CANB) is a vertically integrated
Canadian cannabis company focused on achieving large-scale growth
in the fast-emerging global cannabis market. By targeting organic
growth opportunities alongside the right-fit partners, we remain
focused on finding and capitalizing on chances to grow, diversify
and continue to lead our industry.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
INFORMATION: This news release includes certain
"forward-looking statements" under applicable Canadian securities
legislation. Forward-looking statements include, but are not
limited to, statements with respect to our business and operations
including development and expansion plans; intention to develop
property in British Columbia;
increasing our product lines to include CBD distillates; and our
general business plans. Forward-looking statements are necessarily
based upon a number of assumptions that, while considered
reasonable, are subject to known and unknown risks, uncertainties,
and other factors which may cause actual results and future events
to differ materially from those expressed or implied by such
forward-looking statements. Such factors include, but are not
limited to: compliance with extensive government regulation, the
general business, economic, competitive, political and social
uncertainties; successful negotiation of necessary agreements to
get our product to market; requirement for further capital, delay
or failure to receive board, shareholder or regulatory approvals;
the results of operations and such other matters as set out in the
Filing Statement available on SEDAR at www.sedar.com. There can be
no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements.
Accordingly, readers should not place undue reliance on
forward-looking statements. Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects management's expectations, estimates or
projections concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although we believe
that the expectations reflected in such forward-looking information
are reasonable, such information involves risks and uncertainties,
and undue reliance should not be placed on such information, as
unknown or unpredictable factors could have a material adverse
effect on our future results, performance or achievements.
Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
information prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated,
believed, estimated or expected. Although the Company has attempted
to identify important risks, uncertainties and factors which could
cause actual results to differ materially, there may be others that
cause results not to be as anticipated, estimated or intended.
CanadaBis Capital does not intend, and does not assume any
obligation, to update this forward-looking information except as
otherwise required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE CanadaBis Capital Inc.